These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38789246)

  • 1. Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.
    Jambon A; Forat M; Marchand C; Morel C; Merienne C; Filali S; Pirot F
    Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38789246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products.
    Mathonet S; Mahler HC; Esswein ST; Mazaheri M; Cash PW; Wuchner K; Kallmeyer G; Das TK; Finkler C; Lennard A
    PDA J Pharm Sci Technol; 2016; 70(4):392-408. PubMed ID: 27091885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing of parenteral drug products for visible particles: comparison of the Ph. Eur. method with an alternative method using polarised light.
    Borgonje PE; Dunnewind T; Bosma L; Tokromo-Evegaars M; Meulenhoff PCW; Breukels O
    Eur J Hosp Pharm; 2023 Mar; ():. PubMed ID: 36894297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Machine Learning to the Visual Inspection of Filled Injectable Drug Products.
    Veillon R; Shabushnig J; Aabye-Hansen L; Duvinage M; Eckstein C; Li Z; Sardella A; Soto M; Torres JD; Turnquist B
    PDA J Pharm Sci Technol; 2023; 77(5):376-401. PubMed ID: 37321861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis.
    van den Berg RB; Ganesh M; Crul M; Wilms EB; Swart EL; Westerman EM
    J Pharm Sci; 2024 Jun; ():. PubMed ID: 38852673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for design and use of container challenge sets for qualification and validation of visible particulate inspection.
    Melchore JA; Berdovich D
    PDA J Pharm Sci Technol; 2012; 66(3):273-84. PubMed ID: 22634593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the delamination propensity of pharmaceutical glass vials using a direct stress method.
    Sloey C; Gleason C; Phillips J
    PDA J Pharm Sci Technol; 2013; 67(1):35-42. PubMed ID: 23385562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
    Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
    PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection.
    Allen LV
    Int J Pharm Compd; 2022; 26(3):219-228. PubMed ID: 35657746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.
    Nashed-Samuel Y; Gastwirt J; Kotia RB; Moore S; Masatani P; Torraca G; Goss M; Dolan DG; Akers M; Padala C; Wypych J; Semin DJ
    J Pharm Sci; 2022 Dec; 111(12):3275-3286. PubMed ID: 36116524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of glass particles in parenteral product vials by visual, microscopic, and spectroscopic methods.
    Li GG; Cao S; Jiao N; Wen ZQ
    PDA J Pharm Sci Technol; 2014; 68(4):362-72. PubMed ID: 25035258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of Visible Particles in Parenteral Products by Manual Visual Inspection-Reassessing Size Threshold and Other Particle Characteristics that Define Particle Visibility.
    Mazaheri M; Saggu M; Wuchner K; Koulov AV; Nikels F; Chalus P; Das TK; Cash PW; Finkler C; Levitskaya-Seaman SV; Case J; Parsons J; Gonzalez K
    J Pharm Sci; 2024 Mar; 113(3):616-624. PubMed ID: 37802369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The scientific basis for visible particle inspection.
    Knapp JZ
    PDA J Pharm Sci Technol; 1999; 53(6):291-302. PubMed ID: 10754727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Acid Titration, Conductivity, Flame Photometry, ICP-MS, and Accelerated Lamellae Formation Techniques in Determining Glass Vial Quality.
    Fujimori K; Lee H; Sloey C; Ricci MS; Wen ZQ; Phillips J; Nashed-Samuel Y
    PDA J Pharm Sci Technol; 2016; 70(3):248-55. PubMed ID: 27091889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Absolute" sterility and "absolute" freedom from particle contamination.
    Knapp JZ
    PDA J Pharm Sci Technol; 1998; 52(4):173-81. PubMed ID: 9752713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
    Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
    PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin, result and measurement of USP "essentially free" inspection for visible contaminating particles.
    Knapp JZ
    PDA J Pharm Sci Technol; 2000; 54(3):218-32. PubMed ID: 10927913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Sterility of Single Dose Vials on an Automated Compounding Device.
    Hutchinson HM; Sayre BE; Prettyman T; King E
    Hosp Pharm; 2017 Apr; 52(4):286-293. PubMed ID: 28515508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.